# US 2021/0332053 A1 · Heterocyclic compound and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332053 A1
- Document ID: US20210332053A1
- Status: Published application
- Kind: A1
- Application number: 17/201,878
- Filed: 2021-03-15
- Published: 2021-10-28
- Earliest claimed: 2018-03-28
- Assignees: Takeda Pharmaceutical Company Limited
- Applicants: Takeda Pharmaceutical Company Limited
- Inventors: Yuya OGURO; Shigemitsu MATSUMOTO; Takeshi WAKABAYASHI; Norihito TOKUNAGA; Taku KAMEI; Mitsuhiro ITO; Satoshi MIKAMI; Masaki SETO; Shinji MORIMOTO; Shinji NAKAMURA; Sachie TAKASHIMA; Masataka MURAKAMI; Masaki DAINI; Makoto KAMATA; Minoru NAKAMURA; Yasufumi WADA; Hiroyuki KAKEI; Kazuaki TAKAMI; Taisuke TAWARAISHI; Jumpei AIDA; Kouichi IWANAGA; Satoshi YAMAMOTO
- Web page: https://patentgrep.com/patent/US20210332053A1

## CPC

- C07D 487/04: Ortho-condensed systems
- A61K 9/2095: {Tabletting processes}
- A61K 9/4833: {Encapsulating processes; Filling of capsules (mechanical aspects A61J3/07)}
- A61P 25/00: Drugs for disorders of the nervous system
- C07D 471/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of dementia and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A compound or salt selected from:
N-((6-fluoro[1,2,3]triazolo[1,5-a]pyridin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
N-((4-methyl[1,2,3]triazolo[1,5-a]pyridin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-chloro-4-(difluoromethoxy)-N-((4-methyl[1,2,3]triazolo[1,5-a]pyridin-3-yl)methyl)benzamide;
5-fluoro-6-methoxy-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
3-fluoro-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
3-chloro-4-(difluoromethoxy)-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
5-chloro-6-(difluoromethoxy)-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
5-chloro-6-methoxy-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
3-fluoro-N-((2-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((6-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3,5-difluoro-4-methoxy-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
3-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)nicotinamide;
4-(difluoromethoxy)-3-fluoro-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
3-fluoro-N-(pyrazolo[1,5-a]pyrazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((2-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((4-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((5-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
5-chloro-6-(difluoromethoxy)-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
6-(difluoromethoxy)-5-fluoro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
6-(difluoromethoxy)-N-((2-ethoxypyrazolo[1,5-b]pyridazin-3-yl)methyl)-5-fluoronicotinamide;
4-(difluoromethoxy)-N-((2-ethoxypyrazolo[1,5-b]pyridazin-3-yl)methyl)-3-fluorobenzamide;
6-(difluoromethoxy)-N-((2-ethylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-5-fluoronicotinamide;
4-(difluoromethoxy)-N-((2-ethylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-3-fluorobenzamide;
N-((2-cyclopropylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-6-(difluoromethoxy)-5-fluoronicotinamide;
N-((2-cyclopropylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(difluoromethoxy)-3-fluorobenzamide;
3-chloro-4-(difluoromethoxy)-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((2-(methoxymethyl)pyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-((2-(methoxymethyl)pyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
4-(difluoromethoxy)-3-fluoro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
3-chloro-4-(difluoromethoxy)-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)benzamide;
4-(difluoromethoxy)-3-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)benzamide;
4-(difluoromethoxy)-3-fluoro-N-((4-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((4-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
4-(difluoromethoxy)-3-fluoro-N-((5-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((5-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-chloro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
3,5-difluoro-4-methoxy-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)benzamide;
3-fluoro-N-([1,2,3]triazolo[1,5-a]pyrazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-N-((2-(difluoromethyl)pyrazolo[1,5-b]pyridazin-3-yl)methyl)-5-fluoronicotinamide;
4-(difluoromethoxy)-3-fluoro-N-(pyrazolo[1,5-a]pyrazin-3-ylmethyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-(pyrazolo[1,5-a]pyrazin-3-ylmethyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((2-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-(pyrazolo[1,5-b][1,2,4]triazin-8-ylmethyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((2-methylpyrazolo[1,5-c]pyrimidin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((5-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((5-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((5-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-((4-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((4-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((4-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
6-(difluoromethoxy)-5-fluoro-N-((2-methylpyrazolo[1,5-c]pyrimidin-3-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((2-methylpyrazolo[1,5-c]pyrimidin-3-yl)methyl)nicotinamide;
3-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)nicotinamide;
4-(cyclopropyloxy)-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)benzamide;
5-fluoro-6-methoxy-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)nicotinamide;
3,5-difluoro-4-methoxy-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)benzamide;
4-chloro-3-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)benzamide;
N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-6-(trifluoromethoxy)nicotinamide;
N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-5-(trifluoromethyl)thiophene-2-carboxamide;
N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-4-(trifluoromethyl)benzamide;
3-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)-4-(trifluoromethyl)benzamide;
N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-N-[(1,2-dimethyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
N-[(1,2-dimethyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl)methyl]-3-fluoro-4-(trifluoromethoxy)benzamide;
5-chloro-6-(difluoromethoxy)-N-[(1,2-dimethyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl)methyl]pyridine-3-carboxamide;
6-(difluoromethoxy)-N-[(1,6-dimethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
6-(difluoromethoxy)-N-{[1-(difluoromethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}-5-fluoropyridine-3-carboxamide;
5-chloro-6-(difluoromethoxy)-N-{[1-(difluoromethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}pyridine-3-carboxamide;
6-(difluoromethoxy)-N-{[1-(difluoromethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-5-fluoropyridine-3-carboxamide;
5-chloro-N-{[1-(2,2-difluoroethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}-6-(difluoromethoxy)pyridine-3-carboxamide;
N-{[1-(2,2-difluoroethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}-3-fluoro-4-(trifluoromethoxy)benzamide;
N-{[1-(2,2-difluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-6-(difluoromethoxy)-5-fluoropyridine-3-carboxamide;
5-chloro-N-{[1-(2,2-difluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-6-(difluoromethoxy)pyridine-3-carboxamide;
N-{[1-(2,2-difluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-3-fluoro-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-{[1-(2,2,2-trifluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}pyridine-3-carboxamide;
6-(difluoromethoxy)-N-[(1-ethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
5-chloro-6-(difluoromethoxy)-N-[(1-ethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]pyridine-3-carboxamide;
6-(difluoromethoxy)-N-[(1,2-dimethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
and salts of any of the foregoing.

### Claim 16 (depends on 15)

The compound or salt according to claim 15, which is selected from:
N-((6-fluoro[1,2,3]triazolo[1,5-a]pyridin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
N-((4-methyl[1,2,3]triazolo[1,5-a]pyridin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-chloro-4-(difluoromethoxy)-N-((4-methyl[1,2,3]triazolo[1,5-a]pyridin-3-yl)methyl)benzamide;
5-fluoro-6-methoxy-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
3-fluoro-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
3-chloro-4-(difluoromethoxy)-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
5-chloro-6-(difluoromethoxy)-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
5-chloro-6-methoxy-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
3-fluoro-N-((2-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((6-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3,5-difluoro-4-methoxy-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)nicotinamide;
4-(difluoromethoxy)-3-fluoro-N-(pyrazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
3-fluoro-N-(pyrazolo[1,5-a]pyrazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((2-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((4-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((5-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
5-chloro-6-(difluoromethoxy)-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
6-(difluoromethoxy)-5-fluoro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)nicotinamide;
6-(difluoromethoxy)-N-((2-ethoxypyrazolo[1,5-b]pyridazin-3-yl)methyl)-5-fluoronicotinamide;
4-(difluoromethoxy)-N-((2-ethoxypyrazolo[1,5-b]pyridazin-3-yl)methyl)-3-fluorobenzamide;
6-(difluoromethoxy)-N-((2-ethylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-5-fluoronicotinamide;
4-(difluoromethoxy)-N-((2-ethylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-3-fluorobenzamide;
N-((2-cyclopropylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-6-(difluoromethoxy)-5-fluoronicotinamide;
N-((2-cyclopropylpyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(difluoromethoxy)-3-fluorobenzamide;
3-chloro-4-(difluoromethoxy)-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((2-(methoxymethyl)pyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-((2-(methoxymethyl)pyrazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
4-(difluoromethoxy)-3-fluoro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)benzamide;
3-chloro-4-(difluoromethoxy)-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)benzamide;
4-(difluoromethoxy)-3-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)benzamide;
4-(difluoromethoxy)-3-fluoro-N-((4-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((4-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
4-(difluoromethoxy)-3-fluoro-N-((5-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((5-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-chloro-N-([1,2,3]triazolo[1,5-b]pyridazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
3,5-difluoro-4-methoxy-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)benzamide;
3-fluoro-N-([1,2,3]triazolo[1,5-a]pyrazin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-N-((2-(difluoromethyl)pyrazolo[1,5-b]pyridazin-3-yl)methyl)-5-fluoronicotinamide;
4-(difluoromethoxy)-3-fluoro-N-(pyrazolo[1,5-a]pyrazin-3-ylmethyl)benzamide;
6-(difluoromethoxy)-5-fluoro-N-(pyrazolo[1,5-a]pyrazin-3-ylmethyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((2-methylpyrazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-(pyrazolo[1,5-b][1,2,4]triazin-8-ylmethyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((2-methylpyrazolo[1,5-c]pyrimidin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((5-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((5-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((5-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
3-fluoro-N-((4-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-((4-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((4-methyl[1,2,3]triazolo[1,5-b]pyridazin-3-yl)methyl)nicotinamide;
6-(difluoromethoxy)-5-fluoro-N-((2-methylpyrazolo[1,5-c]pyrimidin-3-yl)methyl)nicotinamide;
5-chloro-6-(difluoromethoxy)-N-((2-methylpyrazolo[1,5-c]pyrimidin-3-yl)methyl)nicotinamide;
3-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-4-(trifluoromethoxy)benzamide;
5-chloro-6-(difluoromethoxy)-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)nicotinamide;
4-(cyclopropyloxy)-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)benzamide;
5-fluoro-6-methoxy-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)nicotinamide;
3,5-difluoro-4-methoxy-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)benzamide;
4-chloro-3-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)benzamide;
N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-6-(trifluoromethoxy)nicotinamide;
N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-5-(trifluoromethyl)thiophene-2-carboxamide;
N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-4-(trifluoromethoxy)benzamide;
3-fluoro-N-((1-methyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl)-4-(trifluoromethyl)benzamide;
3-fluoro-N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)-4-(trifluoromethyl)benzamide;
N-([1,2,3]triazolo[1,5-a]pyridin-3-ylmethyl)-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-N-[(1,2-dimethyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
N-[(1,2-dimethyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl)methyl]-3-fluoro-4-(trifluoromethoxy)benzamide;
5-chloro-6-(difluoromethoxy)-N-[(1,2-dimethyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl)methyl]pyridine-3-carboxamide;
6-(difluoromethoxy)-N-[(1,6-dimethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
6-(difluoromethoxy)-N-{[1-(difluoromethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}-5-fluoropyridine-3-carboxamide;
5-chloro-6-(difluoromethoxy)-N-{[1-(difluoromethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}pyridine-3-carboxamide;
6-(difluoromethoxy)-N-{[1-(difluoromethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-5-fluoropyridine-3-carboxamide;
5-chloro-N-{[1-(2,2-difluoroethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}-6-(difluoromethoxy)pyridine-3-carboxamide;
N-{[1-(2,2-difluoroethyl)-2-methyl-1H-pyrazolo[1,5-b][1,2,4]triazol-7-yl]methyl}-3-fluoro-4-(trifluoromethoxy)benzamide;
N-{[1-(2,2-difluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-6-(difluoromethoxy)-5-fluoropyridine-3-carboxamide;
5-chloro-N-{[1-(2,2-difluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-6-(difluoromethoxy)pyridine-3-carboxamide;
N-{[1-(2,2-difluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}-3-fluoro-4-(trifluoromethoxy)benzamide;
6-(difluoromethoxy)-5-fluoro-N-{[1-(2,2,2-trifluoroethyl)-1H-imidazo[1,2-b]pyrazol-7-yl]methyl}pyridine-3-carboxamide;
6-(difluoromethoxy)-N-[(1-ethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
5-chloro-6-(difluoromethoxy)-N-[(1-ethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]pyridine-3-carboxamide;
6-(difluoromethoxy)-N-[(1,2-dimethyl-1H-imidazo[1,2-b]pyrazol-7-yl)methyl]-5-fluoropyridine-3-carboxamide;
and salts of any of the foregoing.

### Claim 17 (depends on 15)

A pharmaceutical composition comprising:
the compound or salt according to claim 15; and
a pharmacologically acceptable carrier.

### Claim 18 (depends on 16)

A pharmaceutical composition comprising:
the compound or salt according to claim 16; and
a pharmacologically acceptable carrier.

### Claim 19 (depends on 15)

A method for treating a disease or condition selected from major depression, bipolar disorder, migraine, pain, and behavioral and psychological symptoms of dementia in a mammal, comprising administering an effective amount of the compound or salt according to claim 15 to the mammal.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the disease or condition is major depression.

### Claim 21 (depends on 19)

The method according to claim 19, wherein the disease or condition is bipolar disorder.

### Claim 22 (depends on 19)

The method according to claim 19, wherein the disease or condition is migraine.

### Claim 23 (depends on 19)

The method according to claim 19, wherein the disease or condition is pain.

### Claim 24 (depends on 19)

The method according to claim 19, wherein the disease or condition is behavioral and psychological symptoms of dementia.

### Claim 25 (depends on 19)

The method according to claim 19, wherein the mammal is a human.

### Claim 26 (depends on 16)

A method for treating a disease or condition selected from major depression, bipolar disorder, migraine, pain, and behavioral and psychological symptoms of dementia in a mammal, comprising administering an effective amount of the compound or salt according to claim 16 to the mammal.

### Claim 27 (depends on 26)

The method according to claim 26, wherein the disease or condition is major depression.

### Claim 28 (depends on 26)

The method according to claim 26, wherein the disease or condition is bipolar disorder.

### Claim 29 (depends on 26)

The method according to claim 26, wherein the disease or condition is migraine.

### Claim 30 (depends on 26)

The method according to claim 26, wherein the disease or condition is pain.

### Claim 31 (depends on 26)

The method according to claim 26, wherein the disease or condition is behavioral and psychological symptoms of dementia.

### Claim 32 (depends on 26)

The method according to claim 26, wherein the mammal is a human.
